![]() |
Volumn 343, Issue 6168, 2014, Pages 305-309
|
The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL;
BETA CATENIN;
BORTEZOMIB;
CEREBLON UBIQUITIN LIGASE;
CYCLOSPORIN;
DIMETHYLOXALYLGLYCINE;
IKAROS FAMILY ZINC FINGER PROTEIN 1;
IKAROS FAMILY ZINC FINGER PROTEIN 3;
IKAROS TRANSCRIPTION FACTOR;
INTERFERON REGULATORY FACTOR 4;
LENALIDOMIDE;
MYC PROTEIN;
OXYGENASE INHIBITOR;
PEVONEDISTAT;
POMALIDOMIDE;
RAPAMYCIN;
SHORT HAIRPIN RNA;
THALIDOMIDE;
UBIQUITIN PROTEIN LIGASE;
UNCLASSIFIED DRUG;
ZINC FINGER PROTEIN;
BIOCHEMICAL COMPOSITION;
CYPRINID;
CYTOLOGY;
DRUG;
PROTEIN;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DOWN REGULATION;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
ENZYME INHIBITION;
ENZYME SPECIFICITY;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
MULTIPLE MYELOMA;
MYELOMA CELL;
OPEN READING FRAME;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN STABILITY;
TERATOGENICITY;
DANIO RERIO;
|
EID: 84892593087
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1244917 Document Type: Article |
Times cited : (1147)
|
References (29)
|